Skip to content

Supporting Arm and Hand Recovery After Stroke with Non-Invasive Therapy

Effects of Repetitive-Transcranial Magnetic Stimulation on Neurophysiological and Clinical Outcomes in Upper Limb Post-stroke recovery - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093025
Enrollment
66
Registered
2025-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G938- Other specified disorders of brain

Interventions

Intervention1: Repetitive Transcranial Magnetic stimulation (rTMS): Stroke patients with 7 days of Repetitive Transcranial Magnetic stimulation (rTMS) intervention. The treatment protocol involves adm

Sponsors

NIMHANS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with ischemic stroke (based on TOAST criteria) 1. with upper limb motor impairment hemiplegia/monoplegia (based on MRC scale) 2. in early sub-acute phase of stroke 3. age range 18-60 years old 4. anterior circulation stroke 5. with moderate and severe disability modified Rankin Scale (mRS) score ranges from 2 to 5 6. with moderate and severe stroke severity National Institutes of Health Stroke Scale (NIHSS) 5 to 42

Exclusion criteria

Exclusion criteria: 1. Patients who i. are unable to cooperate due to global aphasia ii. are having cerebral venous thrombosis iii. are in ICU ventilators, cardio-respiratory distress iv. are having hemorrhagic stroke v. are having Primary Psychiatric disorders 2. Patients have contraindications to TMS, such as those who i. had a past history or family history of seizures and epilepsy ii. have epileptic discharge in EEG iii. Had a H/O LOC due to seizures and brain tumors iv. have metal implants on the head and neck such as surgical clips, dental implants, cochlear implants, stents in the head and neck v. have undergone decompressive craniotomy vi. having a cardiac pacemaker or cardiac stent vii. are pregnant viii. had a H/O cardiovascular disease such as Ischemic Heart Disease with low ejection fraction and cardiac failure ix. have a history of brain tumor

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of rTMS in post-stroke patients in terms of Clinical outcome measures using BI- Barthel Index, MRS-Modified Rankin Scale, NIHSS- National Institute of Health Stroke Scale, WMFT- Wolf Motor Function Test Timepoint: Baseline- Preintervention Day -1 Postintervention Day-7

Secondary

MeasureTime frame
To evaluate the effect of rTMS in post-stroke patients in terms of Neurophysiological measures using Single-pulse and paired-pulse TMS measures, Heart Rate Variability Measures (HRV) and Electroencephalographic measures (EEG) Timepoint: Baseline- Preintervention Day -1 Postintervention Day-7

Countries

India

Contacts

Public ContactDr Kaviraja Udupa

National Institute of Mental Health and Neurosciences(NIMHANS))

kaviudupa@gmail.com08026995914

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026